Stock News

Better Buy: Bristol Myers Squibb vs. Gilead Sciences
Bristol Myers Reveals Positive Results For Ulcerative Colitis Pivotal Trial
Bristol-Myers Squibb's stock rises on Zeposia trial findings, launch in the U.S.
Bristol Myers' treatment succeeds in late-stage bowel disease study
Hedge Funds Aren’t Done Buying Bristol Myers Squibb Company (BMY)
Cancer Summit Presses Toward Treatments in Covid’s Shadow

As seen on...